Hormone Therapy Added to Radiotherapy Benefits Some With Recurrent Prostate Cancer

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(Medage today) – San Francisco – For patients with recurring prostate cancer, those who have a certain subtype had clinically significant advantages when apalutamide (Erleada) was added to recovery radiotherapy after radical prostatectomy, … randomized … randomized …



